On April 5, 2019, Alex Katz resigned as Chief Financial Officer of CURE Pharmaceutical Holding Corp. (the “Company”), effective immediately. Mark Udell, the Company's current Chief Accounting Officer, Treasurer and Secretary will serve as the Company's Principal Financial Officer.